DETAILS
*HPV-DNA is a mandatory screening test for cervical cancer in women regulated by the FDA.
Cervical cancer is currently the only cancer with a clear cause. HPV infection with the high-risk HPV is found in 97% of cervical cancer patients.
High-risk types of HPV -- especially HPV16 and HPV18 -- cause genital warts, external genital cancer, cervical cancer and high cervical intraepithelial neoplasia.
HPV High Risk Detection: | HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 66 |
HPV Genotyping: | HPV 16, HPV 18 |
Sample type: | Female cervical exfoliated cell |
Application: | |
l Direct detection of HPV-DNA | l More sensitive, specific, accurate and rapid |
l Estimate viral load and cancer risk | l Evaluate HPV vaccine efficacy and prognosis efficacy |
*Comparision between Kindmay FAM fluorescence detection channel and reference reagent

Compared with the reference reagent, Kindmay High-Risk HPV nucleic acid detection kit:
The positive coincidence rate: 92.7%.
The negative coincidence rate: 97.9%.
The overall coincidence rate: 95.3%.